Connect with us

International

US govt endorses Pfizer Covid-19 vaccine

Published

on

US govt endorses Pfizer Covid-19 vaccine

The government of the United States of America has endorsed the Pfizer-BioNTech Covid-19 vaccine as the country gears up for massive inoculation to stem the spread of the virus.

The Pfizer Covid-19 vaccine endorsement was issued on Thursday by the US government advisory panel thus paving the way for the vaccine’s final approval for eventual distribution across the country.

Before the endorsement of the Pfizer Covid-19 vaccine, a panel of outside advisers to the US Food and Drug Administration (FDA) voted 17-4 in favour of the vaccine, with one abstention, deciding that its benefits outweigh any risks for use by individuals.

READ ALSO: Israel receives first batch of Pfizer Covid-19 vaccines

“Americans want us to do a scientific review, but I think they also want us to make sure we’re not wasting time on paperwork as opposed to going forward with the decision,” FDA Commissioner Stephen Hahn said before the meeting.

This came after Ripples Nigeria had reported that the United Kingdom’s medicine regulator has warned that people with a history of anaphylaxis to a medicine or food should not risk taking a shot of the Pfizer-BioNTech Covid-19 vaccine.

This was revealed in a statement issued by June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency (MHRA), thus expanding his guidance on an earlier allergy warning about the Covid-19 vaccine.

Anaphylaxis is an abnormal sensitivity to proteins.

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now